200 SUMMIT DRIVE, BURLINGTON, MA
Investor Presentation
Erik J. Bello Appointed Vice President, Chief Accounting Officer
Earnings Release
Material Contracts, Completing Asset Acquisition or Sale, Reg. FD
Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Other Events
Exhibit 99.1
Q3
Q2
Q1
FY 2025
Notice of Late Filing for Annual Report
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Specialized Disclosure Report
Definitive Revised Proxy Statement